Calendrier des promotions Genenta Science S.p.A.
Calendrier avancé
Graphique simple
À propos de l'entreprise Genenta Science S.p.A.
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. plus de détails| IPO date | 2021-12-15 |
|---|---|
| ISIN | US36870W1009 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | eur |
| Сайт | https://www.genenta.com |
| Цена ао | 4.4 |
| Changement de prix par jour: | -5.24% (5.15) |
|---|---|
| Changement de prix par semaine: | -2.59% (5.01) |
| Changement de prix par mois: | -9.29% (5.38) |
| Changement de prix sur 3 mois: | +24.43% (3.922) |
| Changement de prix sur six mois: | +57.75% (3.0936) |
| Changement de prix par an: | -1.41% (4.95) |
| Evolution du prix sur 3 ans: | 0% (4.88) |
| Evolution du prix sur 5 ans: | 0% (4.88) |
| Evolution des prix sur 10 ans: | 0% (4.88) |
| Evolution des prix depuis le début de l'année: | -8.53% (5.335) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Établissements | Volume | Partager, % |
|---|---|---|
| Bank Julius Baer & Co. Ltd, Zurich | 412547 | 2.26 |
| Algebris (UK) LTD | 45000 | 0.25 |
| UBS Group AG | 2301 | 0.01 |
| Morgan Stanley | 500 | 0 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Dr. Luigi Naldini M.D., Ph.D. | Co-Founder & Chairman of the Executive Scientific Board | N/A | 1959 (66 années) |
| Dr. Bernard Rudolph Gentner M.D., Ph.D. | Co-Founder & Member of the Executive Scientific Board | N/A | 1975 (50 années) |
| Mr. Richard B. Slansky | Chief Financial Officer | N/A | 1958 (67 années) |
| Dr. Carlo Russo M.D. | Chief Medical Officer & Head of Development | N/A | 1953 (72 année) |
| Dr. Stefania Mazzoleni Ph.D. | Director of Program Development | N/A | 1982 (43 année) |
| Ms. Barbara Regonini | Director of Finance | N/A | 1973 (52 année) |
| Mr. Pierluigi Paracchi | Co-Founder, Chairman & CEO | 1973 (52 année) |
Adresse: Italy, Milan, Via Olgettina No. 58 - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.genenta.com
Site web: https://www.genenta.com
